14 studies found for: Open Studies | "Pneumococcal Infections"
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
|2||Not yet recruiting||
Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers
|5||Not yet recruiting||
An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Aerosolized and Intravenous Colistin in Healthy Adults
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection
|9||Not yet recruiting||
Systems Biology of 23-valent Pneumococcal Polysaccharide Vaccine (PNEUMOVAX®23) and 13-valent Pneumococcal Conjugate Vaccine (PREVNAR 13®)
Protection Against Pneumococcal Infection in Children With T1DM
Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
|13||Not yet recruiting||
Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
|14||Not yet recruiting||
Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized Adults
† Indicates status has not been verified in more than two years